Heritable disorders of connective tissue

Bailliere's Best Practice and Research in Clinical Rheumatology

Volumn 14, Issue 2, 2000, Pages 345-361

  Grahame, Rodney ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Benign joint hypermobility syndrome; Ehlers Danlos syndrome; Heritable disorders of connective tissue; Marfan syndrome; Osteogenesis imperfecta

Indexed keywords

BEHAVIOR THERAPY; CHRONIC PAIN; CLINICAL FEATURE; CONNECTIVE TISSUE DISEASE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; EHLERS DANLOS SYNDROME; HUMAN; JOINT HYPERMOBILITY; MARFAN SYNDROME; OSTEOGENESIS IMPERFECTA; PRIORITY JOURNAL; REVIEW;

EID: 0033931848     PISSN: 15216942     EISSN: None     Source Type: Journal    
DOI: 10.1053/berh.1999.0069     Document Type: Article

References (50)

1. Bridges A J, Smith E, Reid J. Joint hypermobility in adults referred to rheumatology clinics. Annals of the Rheumatic Diseases. 51:1992;793-796.
2. Grahame, R, Bird, H, A, British Society for Rheumatology Perceptions about Hypermobility Survey 1999, Rheumatology.
3. Grahame R. Joint hypermobility and genetic collagen disorders. Are they related? Archives of Disease in Childhood. 80:1999;188-191.
4. Grahame R, Pyeritz R E. The Marfan syndrome: joint and skin manifestations are prevalent and correlated. British Journal of Rheumatology. 34:1995;126-131.
5. Dolan A L, Arden N K, Grahame R, Spector T D. Assessment of bone in Ehlers Danlos syndrome by ultrasound and densitometry. Annals of the Rheumatic Diseases. 57:1998;630-633.
6. Mishra M B, Ryan P, Atkinson P. Extra-articular features of benign joint hypermobility syndrome. British Journal of Rheumatology. 35:1996;861-866.
7. Beighton P, Grahame R, Bird H. Hypermobility of Joints. 1999;Springer-Verlag, London.
8. Beighton P, De Paepe A, Danks D. International nosology of heritable disorders of connective tissue, Berlin, 1986. American Journal of Medical Genetics. 29:1988;581-594.
9. De Paepe A, Devereux R B, Dietz H C. Revised diagnostic criteria for the Marfan syndrome. American Journal of Medical Genetics. 62:1996;417-426.
10. Beighton P, De Paepe A, Steinmann B. Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK). American Journal of Medical Genetics. 77:1998;31-37.
11. Grahame, R, Bird, H, A, Dolan, A, L, The 1997 'Brighton' diagnostic criteria for the benign joint hypermobility syndrome, Journal of Rheumatology.
12. Wordsworth P, Ogilvie D, Smith R, Sykes B. Joint mobility with particular reference to racial variation and inherited connective tissue disorders. British Journal of Rheumatology. 26:1987;9-12.
13. Bird H A. Joint hypermobility. British Journal of Rheumatology. 31:1992;205-206.
14. Morgan A W. Report on the hypermobility special interest group, British Society for Rheumatology meeting in Glasgow, April 1995. British Journal of Rheumatology. 35:1996;392-393.
15. Henney A M, Brotherton D H, Child A H. Segregation analysis of collagen genes in two families with joint hypermobility syndrome. British Journal of Rheumatology. 31:1992;169-174.
16. Narcisi P, Richards A J, Ferguson S D, Pope F M. A family with Ehlers-Danlos syndrome type III/articular hypermobility syndrome has a glycine 637 to serine substitution in type III collagen. Human Molecular Genetics. 3:1994;1617-1620.
17. Larsson L G, Baum J, Mudholkar G S. Hypermobility: features and differential incidence between the sexes. Arthritis and Rheumatism. 30:1987;1426-1430.
18. Larsson L-G, Baum J, Mudholkar G S, Srivastava D K. Hypermobility: prevalence and features in a Swedish population. British Journal of Rheumatology. 32:1993;116-119.
19. Beighton P H, Solomon L, Soskolne C L. Articular mobility in an African population. Annals of the Rheumatic Diseases. 32:1973;413-417.
20. Bunnell W P. An objective criterion for scoliosis screening. Journal of Bone and Joint Surgery. 66A:1984;1381-1387.
21. Grahame R, Jenkins J M. Joint hypermobility - asset or liability? A study of joint mobility in ballet dancers. Annals of the Rheumatic Diseases. 31:1972;109-111.
22. Larsson L-G, Baum J, Mudholkar G, Kollia G D. Benefits and disadvantages of joint hypermobility among musicians. New England Journal of Medicine. 329:1993;1079-1082.
23. Sacheti A, Szemere J, Bernstein B. Chronic pain is a manifestation of the Ehlers-Danlos syndrome. Journal of Pain and Symptom Management. 14:1997;88-93.
24. Lumley M, Jordan M, Rubenstein R. Psychosocial functioning in the Ehlers-Danlos syndrome. American Journal of Medical Genetics. 53:1994;149-152.
25. Bulbena A, Duro J C, Porta M. Anxiety disorders in the joint hypermobility syndrome. Psychiatry Research. 46:1993;59-68.
26. Martin-Santos R, Bulbena A, Porta M. Association between joint hypermobility syndrome and panic disorder. American Journal of Psychiatry. 155:1998;1578-1583.
27. Saunders A J, El Sayed T F, Hilson A J. Stress lesions of the lower leg and foot. Clinical Radiology. 30:1979;649-651.
28. Acasuso M, Collantes E, Pujol J. Generalized articular hyperlaxity and musculoligamentous lesions. Revista Espanola de Reumatologia. 21:1994;311-314.
29. Giladi M, Milgrom C, Simkin A, Danon Y. Stress fractures. Identifiable risk factors. American Journal of Sports Medicine. 19:1991;647-652.
30. Wolfe F, Smythe H, Yunus M. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Arthritis and Rheumatism. 32:1990;160-172.
31. Gedalia A, Press J, Klein M, Buskila D. Joint hypermobility and fibromyalgia in schoolchildren. Annals of the Rheumatic Diseases. 52:1993;494-496.
32. Acasuso-Diaz M, Collantes-Estevez E. Joint hypermobility in patients with fibromyalgia syndrome. Arthritis Care and Research. 11:1998;39-42.
33. Adams N. Modulation of nociceptive input. Adams N. The Psychophysiology of Low Back Pain. 1997;47-54 Churchill Livingstone, New York.
34. Mallik A K, Ferrell W R, McDonald A G, Sturrock R D. Impaired proprioceptive acuity at the proximal interphalangeal joint in patients with the hypermobility syndrome. British Journal of Rheumatology. 33:1994;631-637.
35. Hall M G, Ferrell W R, Sturrock R D. The effect of the hypermobility syndrome on knee joint proprioception. British Journal of Rheumatology. 34:1995;121-125.
36. Arendt-Nielsen L, Kaalund S, Bjerring P, Hogsaa B. Insufficient effect of local analgesics in Ehlers-Danlos type III patients (connective tissue disorder). Acta Anaesthesiologica Scandinavica. 34:1990;358-361.
37. Arendt-Nielsen L, Kaalund S, Hogsaa B, Bjerring P. The response of local anaesthetics (EMLA cream) as a clinical test to diagnose between hypermobility and Ehlers-Danlos III syndrome. Scandinavian Journal of Rheumatology. 20:1991;190-195.
38. Gurley-Green, S, Living with the Hypermobility Syndrome, Rheumatology.
39. Harvey W, Grahame R, Panayi G S. Effects of steroid hormones on human fibroblasts in vitro. I. Glucocorticoid action on cell growth and collagen synthesis. Annals of the Rheumatic Diseases. 33:1974;437-441.
40. Barton L M, Bird H A. Improving pain by the stabilization of hyperlax joints. Journal of Orthopaedic Rheumatology. 9:1996;46-51.
41. Beard D J, Dodd C, Trundle H, Simpson A. Proprioceptive enhancement for anterior cruciate ligament deficiency. A prospective randomised trial of two physiotherapy regimes. Journal of Bone and Joint Surgery. 76B:1994;654-659.
42. Bernier J N, Perrin D H. Effect of coordination training on proprioception of the functionally unstable ankle. Journal of Orthopaedic and Sports Physical Therapy. 27:1998;264-275.
43. Harding V, Grahame R. The frequency of joint hypermobility in chronic pain patients. Pain. 5:1990;S500.
44. Williams A CdeC, Nicholas M, Richardson P H. Evaluation of a cognitive behavioural programme for rehabilitating patients with chronic pain. British Journal of General Practice. 43:1993;513-518.
45. Richardson I H, Richardson P H, Williams A CdeC. The effects of a cognitive-behavioural pain management programme on the quality of work and employment status of severely impaired chronic pain patients. Disability and Rehabilitation. 16:1994;26-34.
46. Williams A CdeC, Richardson P, Nicholas M. Inpatient vs outpatient pain management results of a randomised controlled trial. International Association for the Study of Pain. 66:1996;13-22.
47. Astrom E, Soderhall S. Beneficial effect of bisphosphonate during five years of treatment of severe osteogenesis imperfecta. Acta Paediatrica. 87:1998;64-68.
48. Glorieux F H, Bishop N J, Plotkin H. Cyclic administration of pamidronate in children with severe osteogenesis imperfecta. New England Journal of Medicine. 339:1998;947-952.
49. Byers P H. Osteogenesis imperfecta. Royce P LSB. Connective Tissue and its Heritable Disorders. 1993;317-350 Wiley-Liss, New York.
50. Sillence D O, Senn A D. Genetic heterogeneity in osteogenesis imperfecta. Journal of Medical Genetics. 16:1979;101-106.